Erythropoietin exerts cell protective effect by activating PI3K/Akt and MAPK pathways in C6 Cells

References

• Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle DC, Cerami C, . Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Nat Acad Sci USA. 2000;97:10526–31.
   PubMed Web of Science ®Google Scholar
• Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997;76:105–16.
   PubMed Web of Science ®Google Scholar
• Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, . A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab. 1999;19:643–51.
   PubMed Web of Science ®Google Scholar
• Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, . Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol. 2000;401:349–56.
   PubMed Web of Science ®Google Scholar
• Grasso G, Sfacteria A, Meli F, Fodale V, Buemi M, Iacopino DG. Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Res. 2007;1182:99–105.
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Li F, Maiese K. Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res. 2005;2:387–99.
   PubMed Web of Science ®Google Scholar
• Xue YQ, Zhao LR, Guo YR, Duan WM. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Neuroscience. 2007;146:1245–58.
   PubMed Web of Science ®Google Scholar
• Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, . Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40:e647–56.
   PubMed Web of Science ®Google Scholar
• Nirula R, Diaz-Arrastia R, Brasel K, Weigelt JA, Waxman K. Safety and efficacy of erythropoietin in traumatic brain injury patients: a pilot randomized trial. Crit Care Res Pract. 2010; 2010:5–9.
   PubMedGoogle Scholar
• Tseng MY, Hutchinson PJ, Richards HK, Czosnyka M, Pickard JD, Erber WN, . Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. J Neurosurg. 2009;111:171–80.
   PubMed Web of Science ®Google Scholar
• Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, . Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci. 2002;22:10291–301.
   PubMed Web of Science ®Google Scholar
• Siren AL, Knerlich F, Poser W, Gleiter CH, Bruck W, Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. 2001;101:271–6.
   PubMed Web of Science ®Google Scholar
• Bartesaghi S, Marinovich M, Corsini E, Galli CL, Viviani E. Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology. 2005;26:923–8.
   PubMed Web of Science ®Google Scholar
• Genc S, Koroglu TF, Genc K. Erythropoietin and the nervous system. Brain Res. 2004;1000:19–31.
   PubMed Web of Science ®Google Scholar
• Zhang F, Signore AP, Zhou Z, Wang S, Cao G, Chen J. Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J Neurosci Res. 2006;83:1241–51.
   PubMed Web of Science ®Google Scholar
• Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature. 2010;468:232–43.
   PubMed Web of Science ®Google Scholar
• Carnevale D, De Simone R, Minghetti L. Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS Neurol Disord Drug Targets. 2007;6:388–97.
   PubMedGoogle Scholar
• Guo S, Lo EH. Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke. 2009;40:S4–7.
   PubMed Web of Science ®Google Scholar
• Maragakis NJ, Rothstein JD. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol. 2006;2:679–89.
   PubMedGoogle Scholar
• Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol. 2004;72:111–27.
   PubMed Web of Science ®Google Scholar
• Benda P, Lightbody J, Sato G, Levine L, Sweet W. Differentiated rat glial cell strain in tissue culture. Science. 1968;161(3839):370–1.
   PubMed Web of Science ®Google Scholar
• Haghighat N, Oblinger MM, McCandless DW. Cytoprotective effect of estrogen on ammonium chloride-treated C6-glioma cells. Neurochem Res. 2004;29(7):1359–64.
   PubMed Web of Science ®Google Scholar
• Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, . Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci. 1996;8:666–76.
   PubMed Web of Science ®Google Scholar
• Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem. 1994;269:19488–93.
   PubMed Web of Science ®Google Scholar
• Feinstein DL, Galea E, Roberts S, Berquist H, Wang H, Reis DJ. Induction of nitric oxide synthase in rat C6 glioma cells. J Neurochem. 1994;62:315–21.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–9.
   PubMed Web of Science ®Google Scholar
• Mitchell DB, Acosta D. Evaluation of the cytotoxicity of tricyclic antidepressants in primary cultures of rat hepatocytes. J Toxic Environ Health. 1981;7:83–92.
   PubMed Web of Science ®Google Scholar
• Genc K. Erythropoietin and Parkinson's disease: suggested mechanisms and therapeutic implications. Med Hypotheses. 2008;70:211–2.
   PubMed Web of Science ®Google Scholar
• Kumral A, Ozer E, Yilmaz O, Akhisaroglu M, Gokmen N, Duman N, . Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate. 2003;83:224–8.
   PubMedGoogle Scholar
• Iwasaki Y, Ikeda K, Ichikawa Y, Igarashi O, Iwamoto K, Kinoshita M. Protective effect of interleukin-3 and erythropoietin on motor neuron death after neonatal axotomy. Neurol Res. 2002;24:643–6.
   PubMed Web of Science ®Google Scholar
• Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005;6:484–94.
   PubMed Web of Science ®Google Scholar
• Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature. 2001;412:641–7.
   PubMed Web of Science ®Google Scholar
• Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, Merrill JE. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience. 1994;61:575–85.
   PubMed Web of Science ®Google Scholar
• Genc K, Genc S, Baskin H, Semin I. Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes. Physiol Res. 2006;55:33–8.
   PubMed Web of Science ®Google Scholar
• Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, . Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med. 2003;198:971–5.
   PubMed Web of Science ®Google Scholar
• Vairano M, Dello Russo C, Pozzoli G, Battaglia A, Scambia G, Tringali G, . Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci. 2002;16:584–92.
   PubMed Web of Science ®Google Scholar
• Simenc J, Lipnik-Stangelj M. Staurosporine induces different cell death forms in cultured rat astrocytes. Radiol Oncol. 2012;46(4):312–20.
   Web of Science ®Google Scholar
• Shang Y, Wu Y, Yao S, Wang X, Feng D, Yang W. Protective effect of erythropoietin against ketamine-induced apoptosis in cultured rat cortical neurons: involvement of PI3K/Akt and GSK-3 beta pathway. Apoptosis. 2007;12(12):2187–95.
   PubMed Web of Science ®Google Scholar
• Lotharius J, Dugan LL, O'Malley KL. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci. 1999;19(4):1284–93.
   PubMed Web of Science ®Google Scholar
• Dijkmans R, Van Damme J, Cornette F, Heremans H, Billiau A. Bacterial lipopolysaccharide potentiates gamma interferon-induced cytotoxicity for normal mouse and rat fibroblasts. Infect Immun. 1990;58(1):32–6.
   PubMed Web of Science ®Google Scholar
• Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood). 2003;228:1–14.
   PubMed Web of Science ®Google Scholar
• Nagai A, Nakagawa E, Choi HB, Hatori K, Kobayashi S, Kim SU. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol. 2001;60:386–92.
   PubMed Web of Science ®Google Scholar
• Bernaudin M, Bellail A, Marti HH, Yvon A, Vivien D, Duchatelle I, . Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia. 2000;30:271–8.
   PubMed Web of Science ®Google Scholar
• Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res. 2002;44:391–403.
   PubMed Web of Science ®Google Scholar
• Chen ZY, Asavaritikrai P, Prchal JT, Noguchi CT. Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J Biol Chem. 2007;282:25875–83.
   PubMed Web of Science ®Google Scholar
• Kato S, Aoyama M, Kakita H, Hida H, Kato I, Ito T, . Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury. J Neurol Res. 2011;89:1566–74.
   Google Scholar